NuCana (NCNA) Shares Outstanding (Entity) (2015 - 2022)
NuCana (NCNA) Shares Outstanding (Entity) (2015 - 2022) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.16 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 200.18 Mn |
| 10 | NuCana | 14.60 Bn | 14.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 210.34 Bn |
| Mar 31, 2022 | 224.07 Bn |
| Dec 31, 2021 | 224.49 Bn |
| Sep 30, 2021 | 230.12 Bn |
| Jun 30, 2021 | 233.31 Bn |
| Mar 31, 2021 | 227.90 Bn |
| Dec 31, 2020 | 160.07 Bn |
| Sep 30, 2020 | 144.92 Bn |
| Jun 30, 2020 | 129.80 Bn |
| Mar 31, 2020 | 133.23 Bn |
| Dec 31, 2019 | 133.00 Bn |
| Sep 30, 2019 | 127.75 Bn |
| Jun 30, 2019 | 132.71 Bn |
| Mar 31, 2019 | 134.26 Bn |
| Dec 31, 2018 | 131.65 Bn |
| Sep 30, 2018 | 133.71 Bn |
| Jun 30, 2018 | 138.68 Bn |
| Mar 31, 2018 | 141.60 Bn |
| Dec 31, 2017 | 110.75 Bn |
| Sep 30, 2017 | 101.33 Bn |